دورية أكاديمية

Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors

التفاصيل البيبلوغرافية
العنوان: Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors
المؤلفون: Klotz, Laura V., Courty, Yves, Lindner, Michael, Petit-Courty, Agnès, Stowasser, Anja, Koch, Ina, Eichhorn, Martin E., Lilis, Ioannis, Morresi-Hauf, Alicia, Arendt, Kristina A.M., Pepe, Mario, Giopanou, Ioanna, Ntaliarda, Giannoula, Behrend, Sabine J, Oplopoiou, Maria, Gissot, Valérie, Guyétant, Serge, Marchand-Adam, Sylvain, Behr, Jürgen, Kaiser, Jan-Christian, Hatz, Rudolf A, Lamort, Anne-Sophie, Stathopoulos, Georgios T
المصدر: Cancer Medicine (8), 1486-1499. (2019)
سنة النشر: 2019
المجموعة: Institut National de la Recherche Agronomique: ProdINRA
مصطلحات موضوعية: Médecine humaine et pathologie, Human health and pathology, Cancer, Pneumologie et système respiratoire, Pulmonology and respiratory tract, LADC, lung adenocarcinoma, obstruction, smoking, survival, adénocarcinome, poumon, tabagisme, résection
الوصف: A comprehensive characterization of lung adenocarcinoma (LADC) clinical features is currently missing. We prospectively evaluated Caucasian patients with early-stage LADC. Patients with LADC diagnosed between 2011 and 2015 were prospectively assessed for lung resection with curative intent. Fifty clinical, pathologic, radiologic, and molecular variables were recorded. Patients were followed till death/study conclusion. The main findings were compared to a separate cohort from France. Of 1943 patients evaluated, 366 were enrolled (18.8%; 181 female; 75 never-smokers; 28% of registered Bavarian cases over the study period). Smoking and obstruction were significantly more prevalent in GLAD compared with adult Bavarians (P < 0.0001). Ever-smoker tumors were preferentially localized to the upper lobes. We observed 120 relapses and 74 deaths over 704 cumulative follow-up years. Median overall and disease-free survival were >7.5 and 3.6 years, respectively. Patients aged <45 or >65 years, resected >60 days postdiagnosis, with abnormal FVC/DLCO VA , N2/N3 stage, or solid histology had significantly decreased survival estimates. These were fit into a weighted locoregional LADC death risk score that outperformed pTNM7 in predicting survival in the GLAD and in our second cohort. We define the clinical gestalt of locoregional LADC and provide a new clinical tool to predict survival, findings that may aid future management and research design
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
DOI: 10.1002/cam4.2031
الإتاحة: https://doi.org/10.1002/cam4.2031Test
http://prodinra.inra.fr/ft/5BB29879-7BA4-4681-9670-1169F1727881Test
http://prodinra.inra.fr/record/465332Test
حقوق: https://creativecommons.org/licenses/by/3.0Test/
رقم الانضمام: edsbas.481C2BD0
قاعدة البيانات: BASE